A BILL 
To amend the Federal Food, Drug, and Cosmetic Act to 
waive or reduce the amount of over-the-counter mono-
graph fees applicable to small businesses, and for other 
purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Small Business FDA 
4
User Fee Adjustment Act of 2021’’. 
5
03:51 Jul 24, 2021
H4405
2 
•HR 4405 IH
SEC. 2. WAIVER AND REDUCTION OF OTC MONOGRAPH 
1
FEES FOR SMALL BUSINESSES. 
2
(a) IN GENERAL.—Section 744M of the Federal 
3
Food, Drug, and Cosmetic Act (21 U.S.C. 379j–72) is 
4
amended— 
5
(1) by redesignating subsections (d) through (h) 
6
as subsections (e) through (i), respectively; and 
7
(2) by inserting after subsection (c) the fol-
8
lowing: 
9
‘‘(d) FEE WAIVER
AND REDUCTION
FOR SMALL 
10
BUSINESSES.— 
11
‘‘(1) IN GENERAL.—Beginning with respect to 
12
fiscal year 2022: 
13
‘‘(A) The Secretary shall waive the fee 
14
under subsection (a)(2) with respect to the first 
15
OTC monograph order request that a small 
16
business submits to the Secretary for review. 
17
‘‘(B) The Secretary shall reduce the fees 
18
that are applicable to a small business under 
19
subsections (a)(1) (facility fees) and (a)(2) 
20
(OTC monograph order request fees), and not 
21
waived under subparagraph (A), to 25 percent 
22
of the amount otherwise owed. 
23
‘‘(2) CERTIFICATION.—The Secretary shall re-
24
quire any person who applies for a waiver or reduc-
25
tion of fees under paragraph (1) to certify their 
26
03:51 Jul 24, 2021
H4405
3 
•HR 4405 IH
qualification for the waiver or reduction. The Sec-
1
retary shall periodically publish in the Federal Reg-
2
ister a list of persons making such certifications. 
3
‘‘(3) SMALL BUSINESS DEFINED.—In this sub-
4
section, the term ‘small business’ means an entity 
5
that has fewer than 500 employees, including em-
6
ployees of affiliates’’. 
7
(b) CONFORMING
CHANGE
TO
FEE
REVENUE 
8
AMOUNTS.—Section 744M(b)(2) of the Federal Food, 
9
Drug, and Cosmetic Act (21 U.S.C. 379j–72(b)(2)) is 
10
amended by striking ‘‘For each of the fiscal years 2022 
11
through 2025’’ and inserting ‘‘Subject to subsection (d), 
12
for each of the fiscal years 2022 through 2025’’. 
13
Æ 
03:51 Jul 24, 2021
H4405
